Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)

Cytokine and Growth Factor Reviews

Volumn 24, Issue 1, 2013, Pages 59-68

  Charrier, Alyssa ^a,b   Brigstock, David R ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

cell; Acinar cell; CCN; CCN2; Connective tissue growth factor; CTGF; Desmoplasia; Fibrosis; Islets; Matricellular; Pancreatic ductal adenocarcinoma; Pancreatic stellate cell; TGF

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CONNECTIVE TISSUE GROWTH FACTOR; FG 3019; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; REPARIXIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; AUTOCRINE EFFECT; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS CANCER; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PANCREAS NECROSIS; PANCREATIC STELLATE CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; SHORT SURVEY; TUMOR REGRESSION;

ADENOCARCINOMA; ANIMALS; AUTOCRINE COMMUNICATION; CARCINOMA, PANCREATIC DUCTAL; CONNECTIVE TISSUE GROWTH FACTOR; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION;

EID: 84874256781     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.07.001     Document Type: Short Survey

References (75)

1. Brigstock D.R. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999, 20:189-206.
2. Brigstock D.R., Goldschmeding R., Katsube K.I., Lam S.C., Lau L.F., Lyons K., et al. Proposal for a unified CCN nomenclature. Mol Pathol 2003, 56:127-128.
3. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993, 327:125-130.
4. Rachfal A.W., Brigstock D.R. Structural and functional properties of CCN proteins. Vitam Horm 2005, 70:69-103.
5. Chen C.C., Lau L.F. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009, 41:771-783.
6. Lau L.F. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 2011, 68:3149-3163.
7. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999, 248:44-57.
8. Gao R., Brigstock D.R. Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003, 27:214-220.
9. Kawata K., Kubota S., Eguchi T., Aoyama E., Moritani N.H., Kondo S., et al. Role of low-density lipoprotein receptor related protein 1 (LRP1) in CCN2/connective tissue growth factor (CTGF) protein transport in chondrocytes. J Cell Sci 2012, [Epub ahead of print] PMID: 22454511. 10.1242/jcs.101956.
10. Wahab N.A., Weston B.S., Mason R.M. Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 2005, 16:340-351.
11. Mo F.E., Lau L.F. The matricellular protein CCN1 is essential for cardiac development. Circ Res 2006, 99:961-969.
12. Mo F.E., Muntean A.G., Chen C.C., Stolz D.B., Watkins S.C., Lau L.F. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002, 22:8709-8720.
13. Baguma-Nibasheka M., Kablar B. Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse. Dev Dyn 2008, 237:485-493.
14. Ivkovic S., Yoon B.S., Popoff S.N., Safadi F.F., Libuda D.E., Stephenson R.C., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003, 130:2779-2791.
15. Crawford L.A., Guney M.A., Oh Y.A., Deyoung R.A., Valenzuela D.M., Murphy A.J., et al. Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis. Mol Endocrinol 2009, 23:324-336.
16. Heath E., Tahri D., Andermarcher E., Schofield P., Fleming S., Boulter C.A. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol 2008, 8:18.
17. Hurvitz J.R., Suwairi W.M., Van Hul W., El-Shanti H., Superti-Furga A., Roudier J., et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999, 23:94-98.
18. Guney M.A., Petersen C.P., Boustani A., Duncan M.R., Gunasekaran U., Menon R., et al. Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells. Proc Natl Acad Sci USA 2011, 108:15242-15247.
19. Prado C.L., Pugh-Bernard A.E., Elghazi L., Sosa-Pineda B., Sussel L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 2004, 101:2924-2929.
20. Apte M.V., Haber P.S., Applegate T.L., Norton I.D., McCaughan G.W., Korsten M.A., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133.
21. Apte M., Pirola R., Wilson J. The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells. Antioxid Redox Signal 2011, 15:2711-2722.
22. Haber P.S., Keogh G.W., Apte M.V., Moran C.S., Stewart N.L., Crawford D.H., et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999, 155:1087-1095.
23. Gao R., Brigstock D.R. Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 2005, 129:1019-1030.
24. Gao R., Brigstock D.R. A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut 2006, 55:856-862.
25. Lawrencia C., Charrier A., Huang G., Brigstock D.R. Ethanol-mediated expression of connective tissue growth factor (CCN2) in mouse pancreatic stellate cells. Growth Factors 2009, 27:91-99.
26. Shinji T., Ujike K., Ochi K., Kusano N., Kikui T., Matsumura N., et al. Establishment of a novel collagenase perfusion method to isolate rat pancreatic stellate cells and investigation of their gene expression of TGF-beta1, type I collagen, and CTGF in primary culture or freshly isolated cells. Acta Med Okayama 2002, 56:211-218.
27. Pan F.C., Wright C. Pancreas organogenesis: from bud to plexus to gland. Dev Dyn 2011, 240:530-565.
28. Rojas A., Khoo A., Tejedo J.R., Bedoya F.J., Soria B., Martin F. Islet cell development. Adv Exp Med Biol 2010, 654:59-75.
29. Kim S.K., MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 2002, 12:540-547.
30. Gradwohl G., Dierich A., LeMeur M., Guillemot F. Neurogenin 3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000, 97:1607-1611.
31. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
32. Yoon K.H., Ko S.H., Cho J.H., Lee J.M., Ahn Y.B., Song K.H., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003, 88:2300-2308.
33. Surveyor G.A., Brigstock D.R. Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors 1999, 17:115-124.
34. Wilding Crawford L., Tweedie Ables E., Oh Y.A., Boone B., Levy S., Gannon M. Gene expression profiling of a mouse model of pancreatic islet dysmorphogenesis. PLoS One 2008, 3:e1611.
35. Kapasa M., Serafimidis I., Gavalas A., Kossida S. Identification of phylogenetically conserved enhancer elements implicated in pancreas development in the WISP1 and CTGF orthologs. Genomics 2008, 92:301-308.
36. Gunasekaran U., Hudgens C.W., Wright B.T., Maulis M.F., Gannon M. Differential regulation of embryonic and adult beta cell replication. Cell Cycle 2012, 11.
37. Ammann R.W., Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut 1994, 35:552-556.
38. Leask A., Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 2004, 18:816-827.
39. Verrecchia F., Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007, 13:3056-3062.
40. Friess H., Lu Z., Riesle E., Uhl W., Brundler A.M., Horvath L., et al. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg 1998, 227:95-104.
41. Konturek P.C., Dembinski A., Warzecha Z., Ihlm A., Ceranowicz P., Konturek S.J., et al. Comparison of epidermal growth factor and transforming growth factor-beta1 expression in hormone-induced acute pancreatitis in rats. Digestion 1998, 59:110-119.
42. Menke A., Yamaguchi H., Gress T.M., Adler G. Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. Gastroenterology 1997, 113:295-303.
43. Muller-Pillasch F., Gress T.M., Yamaguchi H., Geng M., Adler G., Menke A. The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis. Pancreas 1997, 15:168-175.
44. Riesle E., Friess H., Zhao L., Wagner M., Uhl W., Baczako K., et al. Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut 1997, 40:73-79.
45. Lee M.S., Gu D., Feng L., Curriden S., Arnush M., Krahl T., et al. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol 1995, 147:42-52.
46. Van Laethem J.L., Robberecht P., Resibois A., Deviere J. Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 1996, 110:576-582.
47. Leask A., Abraham D.J. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003, 81:355-363.
48. di Mola F.F., Friess H., Riesle E., Koliopanos A., Buchler P., Zhu Z., et al. Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis. Ann Surg 2002, 235:60-67.
49. di Mola F.F., Friess H., Martignoni M.E., Di Sebastiano P., Zimmermann A., Innocenti P., et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999, 230:63-71.
50. Charrier A.L., Brigstock D.R. Connective tissue growth factor production by activated pancreatic stellate cells in mouse alcoholic chronic pancreatitis. Lab Invest 2010, 90:1179-1188.
51. Vogelmann R., Ruf D., Wagner M., Adler G., Menke A. Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 2001, 280:G164-G172.
52. Fitzner B., Brock P., Nechutova H., Glass A., Karopka T., Koczan D., et al. Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cell Signal 2007, 19:782-790.
53. Hong O.K., Lee S.H., Rhee M., Ko S.H., Cho J.H., Choi Y.H., et al. Hyperglycemia and hyperinsulinemia have additive effects on activation and proliferation of pancreatic stellate cells: possible explanation of islet-specific fibrosis in type 2 diabetes mellitus. J Cell Biochem 2007, 101:665-675.
54. Karger A., Fitzner B., Brock P., Sparmann G., Emmrich J., Liebe S., et al. Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal 2008, 20:1865-1872.
55. Ko S.H., Hong O.K., Kim J.W., Ahn Y.B., Song K.H., Cha B.Y., et al. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 2006, 98:343-355.
56. Korc M. Pancreatic cancer-associated stroma production. Am J Surg 2007, 194:S84-S86.
57. Hartel M., di Mola F.F., Gardini A., Zimmermann A., Di Sebastiano P., Guweidhi A., et al. Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 2004, 28:818-825.
58. Wenger C., Ellenrieder V., Alber B., Lacher U., Menke A., Hameister H., et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene 1999, 18:1073-1080.
59. Iacobuzio-Donahue C.A., Ryu B., Hruban R.H., Kern S.E. Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. Am J Pathol 2002, 160:91-99.
60. Bennewith K.L., Huang X., Ham C.M., Graves E.E., Erler J.T., Kambham N., et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009, 69:775-784.
61. Mantoni T.S., Schendel R.R., Rodel F., Niedobitek G., Al-Assar O., Masamune A., et al. Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Biol Ther 2008, 7:1806-1815.
62. Pickles M., Leask A. Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERK. J Cell Commun Signal 2007, 1:85-90.
63. Kwon S., Munroe X., Crawley S.C., Lee H.Y., Spong S., Bradham D., et al. Expression of connective tissue growth factor in pancreatic cancer cell lines. Int J Oncol 2007, 31:693-703.
64. Klimstra D.S., Longnecker D.S. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994, 145:1547-1550.
65. Rozenblum E., Schutte M., Goggins M., Hahn S.A., Panzer S., Zahurak M., et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997, 57:1731-1734.
66. Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Fujitani Y., Fujitani S., et al. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 2006, 20:3147-3160.
67. Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Bierie B., Tada M., et al. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J Clin Invest 2011, 121:4106-4117.
68. Behrens M.E., Grandgenett P.M., Bailey J.M., Singh P.K., Yi C.H., Yu F., et al. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene 2010, 29:5667-5677.
69. Ryu B., Jones J., Hollingsworth M.A., Hruban R.H., Kern S.E. Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001, 61:1833-1838.
70. Aikawa T., Gunn J., Spong S.M., Klaus S.J., Korc M. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther 2006, 5:1108-1116.
71. Dornhofer N., Spong S., Bennewith K., Salim A., Klaus S., Kambham N., et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2006, 66:5816-5827.
72. Youns M., Efferth T., Hoheisel J.D. Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells. Eur J Pharmacol 2011, 650:170-177.
73. Jun J.I., Lau L.F. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 2011, 10:945-963.
74. Kular L., Pakradouni J., Kitabgi P., Laurent M., Martinerie C. The CCN family: a new class of inflammation modulators?. Biochimie 2011, 93:377-388.
75. Le Dreau G., Kular L., Nicot A.B., Calmel C., Melik-Parsadaniantz S., Kitabgi P., et al. NOV/CCN3 upregulates CCL2 and CXCL1 expression in astrocytes through beta1 and beta5 integrins. Glia 2010, 58:1510-1521.